Northland Trims Salesforce (CRM) Valuation Following Earnings Report

Key Takeaways

• Northland cut Salesforce target to $202, down from $229
• BMO lowered price goal to $215, keeping Outperform rating
• Analysts cite slowing constant‑currency cRPO growth post‑Q1 earnings
• Revenue guidance unchanged, but investors watch FY2027 growth sustainability
• Salesforce’s valuation deemed undemanding despite mixed growth signals

Pulse Analysis

Salesforce’s latest earnings report delivered solid top‑line numbers, yet the growth rate of its subscription base raised eyebrows. The company posted revenue that beat consensus, driven by higher AI‑enabled offerings and expanding services, but the constant‑currency current remaining performance obligation (cRPO) – a key metric for future subscription revenue – showed a deceleration. This nuance prompted analysts to reassess the stock’s upside, especially as investors increasingly focus on sustainable, recurring revenue streams in the competitive CRM landscape.

In response, Northland’s Nehal Chokshi reduced the price target to $202 from $229, citing the cRPO slowdown as a red flag, while retaining a Market Perform rating. BMO Capital mirrored this sentiment, trimming its target to $215 yet maintaining an Outperform stance, emphasizing that the guidance for fiscal 2027 revenue remains largely intact. Both firms argue that Salesforce’s current valuation is still attractive, but the margin for error has narrowed. The consensus now hinges on whether the company can translate its AI investments into consistent, high‑margin growth without eroding subscription renewal rates.

The broader implication for the CRM sector is a heightened scrutiny of subscription health metrics. As AI‑driven competitors vie for market share, investors are demanding clearer evidence of durable revenue expansion. Salesforce’s mixed signals may prompt a reallocation of capital toward AI‑centric firms perceived to offer higher upside with lower downside. Nonetheless, the stock’s entrenched enterprise footprint and ongoing product innovation keep it on many investors’ watchlists, making the next earnings cycle a pivotal moment for gauging long‑term momentum.